£359.3 M

Dechra Pharmaceuticals Revenue FY, 2017
Dechra Pharmaceuticals Gross profit (FY, 2017)191.7 M
Dechra Pharmaceuticals Gross profit margin (FY, 2017), %53.4%
Dechra Pharmaceuticals Net income (FY, 2017)26.1 M
Dechra Pharmaceuticals EBITDA (FY, 2017)80.5 M
Dechra Pharmaceuticals EBIT (FY, 2017)33.2 M
Dechra Pharmaceuticals Cash, 30-Jun-201761.2 M
Dechra Pharmaceuticals EV1.8 B

Dechra Pharmaceuticals Revenue

Dechra Pharmaceuticals revenue was £359.28 m in FY, 2017

Embed Graph

Dechra Pharmaceuticals Income Statement

Annual

GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

137.2m145.9m145.5m156.4m170.2m179.3m186.8m208.2m232.5m253.8m189.2m193.6m203.5m247.6m359.3m

Revenue growth, %

2%5%22%

Cost of goods sold

123.8m131.4m128.6m137.2m149.7m156.3m161.4m178.5m199.2m217.0m88.5m85.9m87.3m115.1m167.6m

Gross profit

13.4m14.5m16.9m19.2m20.5m23.0m25.4m29.7m33.3m36.9m100.7m107.7m116.1m132.4m191.7m

Gross profit Margin, %

10%10%12%12%12%13%14%14%14%15%53%56%57%53%53%

Operating expense total

7.9m8.5m9.4m12.0m12.1m15.9m16.9m19.3m21.0m23.0m82.4m82.7m90.2m112.9m158.5m

EBITDA

15.0m41.0m45.5m47.5m44.8m80.5m

EBITDA margin, %

6%22%24%23%18%22%

EBIT

5.5m6.0m7.5m7.2m8.5m7.1m8.5m10.4m12.3m13.8m18.3m25.0m26.0m19.5m33.2m

EBIT margin, %

4%4%5%5%5%4%5%5%5%5%10%13%13%8%9%

Pre tax profit

77.0k417.0k2.1m4.8m7.3m5.7m7.4m8.9m11.0m12.6m12.5m21.4m25.8m14.5m28.6m

Income tax expense

(68.0k)(246.0k)(652.0k)(1.7m)(2.2m)(1.9m)(2.3m)(2.6m)(3.5m)(3.8m)(1.6m)(2.0m)(6.3m)(2.0m)(2.5m)

Net Income

9.0k171.0k1.4m3.0m5.1m3.8m5.1m6.3m7.6m8.8m10.9m19.4m19.5m12.5m26.1m

Dechra Pharmaceuticals Balance Sheet

Annual

GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

4.2m4.7m9.2m4.0m13.9m19.7m17.2m32.8m26.8m45.9m39.1m61.2m

Accounts Receivable

16.6m18.7m20.7m23.2m24.6m26.8m31.3m31.8m33.5m34.0m25.3m28.3m27.7m59.2m59.7m

Inventories

9.3m11.7m16.2m16.5m19.3m17.3m17.0m20.4m22.0m25.7m29.2m29.7m31.7m54.4m56.5m

Current Assets

31.3m36.0m47.9m44.6m45.1m45.3m49.9m68.0m77.0m79.1m179.5m86.3m108.6m162.4m185.0m

PP&E

2.5m2.5m2.6m4.3m6.3m5.6m5.2m5.2m6.0m5.7m16.1m18.3m16.8m37.7m45.2m

Goodwill

196.2m166.7m360.4m

Total Assets

33.8m38.5m50.5m48.9m56.7m56.6m60.3m78.9m90.6m98.0m415.1m300.8m293.5m556.2m638.4m

Accounts Payable

19.6m23.0m34.5m31.1m31.7m29.2m33.2m38.2m42.0m44.0m11.9m12.9m10.4m24.3m21.4m

Current Liabilities

23.3m27.9m40.4m39.0m42.4m42.4m45.2m47.2m51.5m55.6m103.5m35.7m44.1m66.0m66.4m

Non-Current Liabilities

40.0m39.9m37.9m9.0m8.5m6.7m4.9m17.3m15.2m11.9m137.0m60.3m54.9m215.6m270.9m

Total Debt

5.7m3.3m1.4m3.0m4.0m9.4m1.6m965.0k

Total Liabilities

63.4m67.9m78.4m48.0m51.0m49.1m50.1m64.5m66.7m67.5m240.5m96.0m99.0m281.5m337.3m

Additional Paid-in Capital

6.0k6.0k6.0k498.0k504.0k510.0k510.0k511.0k519.0k528.0k872.0k877.0k880.0k927.0k932.0k

Retained Earnings

9.0k171.0k1.4m1.2m3.0m1.7m2.7m3.6m4.8m5.3m6.7m6.8m5.6m(2.6m)8.4m

Total Equity

(29.5m)(29.4m)(27.9m)901.0k5.7m7.5m10.2m14.5m23.9m30.5m174.6m204.8m194.5m274.6m301.1m

Debt to Equity Ratio

0.8 x0.3 x0.1 x0.1 x0.1 x0.1 x0 x0 x

Debt to Assets Ratio

0.1 x0.1 x0 x0 x0 x0 x0 x0 x

Financial Leverage

-1.1 x-1.3 x-1.8 x54.3 x9.9 x7.6 x5.9 x5.5 x3.8 x3.2 x2.4 x1.5 x1.5 x2 x2.1 x

Dechra Pharmaceuticals Cash Flow

Annual

GBPFY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

9.0k171.0k1.4m3.0m5.1m3.8m5.1m6.3m7.6m8.8m10.9m19.4m19.5m12.5m26.1m

Cash From Operating Activities

6.4m5.4m12.0m3.5m6.4m6.5m10.6m13.2m9.5m9.2m36.9m11.5m41.0m43.6m77.4m

Dividends Paid

1.9m2.1m2.1m2.4m2.7m2.8m3.6m11.2m12.6m13.9m15.3m17.7m

Cash From Financing Activities

39.9m(1.4m)(2.5m)2.7m(765.0k)(3.4m)(2.6m)11.8m(2.9m)(6.7m)(18.3m)(92.1m)(14.8m)125.3m1.6m

Net Change in Cash

4.2m541.0k4.5m5.2m6.1m3.6m2.4m17.2m5.8m(2.5m)(769.0k)(4.1m)21.5m(5.1m)21.7m

Income Taxes Paid

(2.0m)(6.3m)(2.0m)

Dechra Pharmaceuticals Ratios

GBPY, 2017

EV/EBITDA

23 x

EV/EBIT

55.7 x

EV/CFO

23.9 x

Revenue/Employee

271.6k

Financial Leverage

2.1 x
Report incorrect company information